atopic%20dermatitis
ATOPIC DERMATITIS
Atopic dermatitis or atopic eczema is a chronic, relapsing, familial, symmetric and pruritic inflammatory skin disease that commonly presents during early infancy and childhood, but can persist or start in adulthood.
It is commonly associated with elevated serum immunoglobulin E levels and a personal or family history of allergies, allergic rhinitis and asthma.
It is one of the most common skin diseases afflicting both children and adults.

Patient Education

  • Discuss the chronic nature of atopic dermatitis, exacerbating factors and appropriate treatment options
    • Emphasize that atopic dermatitis tends to decrease with increase in age
  • Convey the goal of treatment is control rather than “cure”
  • Discuss that many factors probably contribute to flare-ups and usually a specific cause cannot be found
  • Educate the patient about proper skin care (eg bathing, hydration and use of moisturizers)
    • Patient/caregiver should be instructed to apply emollients liberally 3 minutes after taking a bath 2-3 times daily or frequently as the skin gets dry even in the absence of symptoms
    • Studies showed that correct and adequate instructions for use and application of moisturizers when done properly reduces disease severity and overall topical corticosteroids use
  • Explain potential side effects of medications when used over extended periods of time
    • Apply topical steroid 10-15 minutes after application of emollients
  • Keep fingernails trimmed short
  • Use of cotton gloves at night to limit scratching
Editor's Recommendations
Most Read Articles
Pearl Toh, 6 days ago
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
Stephen Padilla, 19 Mar 2020
The assumption that children are less vulnerable to the coronavirus disease 2019 (COVID-19) compared to adults is not quite true and may even be dangerous, suggests a recent study.
22 Mar 2020
Sustained use of lopinavir-combined regimen appears to confer benefits among patients with the novel coronavirus disease (COVID-19), with improvement possibly indicated by increasing eosinophils, suggests a recent study.
24 Mar 2020
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.